First human test: scientists track new Drug's journey in healthy volunteers
NCT ID NCT07448155
Summary
This is a very early study to understand how a new drug called INCA033989 moves through the body and to check its safety. It will involve 72 healthy adults who will receive a single dose, either as an injection under the skin or through an IV. The main goals are to measure the drug levels in the blood and monitor for any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Celerion Clinical Research Unit
RECRUITINGTempe, Arizona, 85283, United States
Conditions
Explore the condition pages connected to this study.